DE69424537D1 - Therapeutischer wirkstoff zur behandlung von melanomen - Google Patents

Therapeutischer wirkstoff zur behandlung von melanomen

Info

Publication number
DE69424537D1
DE69424537D1 DE69424537T DE69424537T DE69424537D1 DE 69424537 D1 DE69424537 D1 DE 69424537D1 DE 69424537 T DE69424537 T DE 69424537T DE 69424537 T DE69424537 T DE 69424537T DE 69424537 D1 DE69424537 D1 DE 69424537D1
Authority
DE
Germany
Prior art keywords
active substance
therapeutic active
melanomas
component
treating melanomas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69424537T
Other languages
English (en)
Other versions
DE69424537T2 (de
Inventor
Lance Elliot Schlipalius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis Australia Pty Ltd
Original Assignee
Betatene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Betatene Ltd filed Critical Betatene Ltd
Application granted granted Critical
Publication of DE69424537D1 publication Critical patent/DE69424537D1/de
Publication of DE69424537T2 publication Critical patent/DE69424537T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE69424537T 1993-03-22 1994-03-22 Therapeutischer wirkstoff zur behandlung von melanomen Expired - Fee Related DE69424537T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL793493 1993-03-22
PCT/AU1994/000141 WO1994021231A1 (en) 1993-03-22 1994-03-22 Therapeutic agent for the treatment of melanomas

Publications (2)

Publication Number Publication Date
DE69424537D1 true DE69424537D1 (de) 2000-06-21
DE69424537T2 DE69424537T2 (de) 2001-11-15

Family

ID=3776793

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69424537T Expired - Fee Related DE69424537T2 (de) 1993-03-22 1994-03-22 Therapeutischer wirkstoff zur behandlung von melanomen

Country Status (10)

Country Link
US (2) US5705180A (de)
EP (1) EP0689426B1 (de)
JP (1) JPH08510994A (de)
AT (1) ATE192921T1 (de)
DE (1) DE69424537T2 (de)
DK (1) DK0689426T3 (de)
ES (1) ES2149264T3 (de)
GR (1) GR3034167T3 (de)
PT (1) PT689426E (de)
WO (1) WO1994021231A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM493194A0 (en) * 1994-04-08 1994-05-05 Buckmeier, Julie A. Therapeutic agent for inhibiting the conversion of epithelial cells to tumours
US6428816B1 (en) * 1994-04-08 2002-08-06 Cognis Australia Pty., Ltd. Carotenoid agent for inhibiting the conversion of epithelial cells to tumors
DE19609476A1 (de) * 1996-03-11 1997-09-18 Basf Ag Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
EP0984915A4 (de) 1997-04-04 2002-11-27 Henkel Corp Luteinester mit hoher bioverfügbarkeit
GB9718636D0 (en) * 1997-09-04 1997-11-05 Smithkline Beecham Plc Novel composition and use
US20070087993A1 (en) 1999-07-29 2007-04-19 Steven Baranowitz Method for transdifferentiation of body tissues
US7070796B1 (en) * 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
US6277417B1 (en) * 2000-04-07 2001-08-21 Triarco Industries, Inc. Method of inhibiting 5α-reductase with astaxanthin
WO2002047725A2 (fr) * 2000-12-12 2002-06-20 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
US6635293B2 (en) * 2001-10-23 2003-10-21 Kemin Foods, L.C. Finely dispersed carotenoid suspensions for use in foods and a process for their preparation
US6759436B2 (en) 2002-02-01 2004-07-06 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US6890961B2 (en) * 2002-02-01 2005-05-10 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
CA2495167C (en) * 2002-07-29 2018-08-21 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US7074990B2 (en) * 2003-06-27 2006-07-11 Agricultural Research Organization, The Volcani Center Carotenoids rich paprika cultivars
JP4526244B2 (ja) 2003-06-30 2010-08-18 ブラザー工業株式会社 インクジェットヘッド及びインクジェットプリンタ並びにインクジェットヘッドの製造方法
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005102356A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005105040A2 (en) * 2004-04-26 2005-11-10 Micelle Products, Inc. Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
US4680314A (en) * 1985-08-30 1987-07-14 Microbio Resources, Inc. Process for producing a naturally-derived carotene/oil composition by direct extraction from algae
AU595824B2 (en) * 1985-08-30 1990-04-12 Betatene Limited Narurally-derived carotene/oil composition and the process for the production thereof by direct extraction of carotene from algae
WO1989006977A1 (en) * 1988-02-04 1989-08-10 Board Of Regents, The University Of Texas System Formulation and use of retinoids in treatment of cancer and other diseases
JPH0225418A (ja) * 1988-07-14 1990-01-26 Kyorin Pharmaceut Co Ltd イブジラスト脂肪乳剤およびその製造方法
EP0400547A1 (de) * 1989-06-02 1990-12-05 Abbott Laboratories Parenterales Nahrungsmittel
US5196198A (en) * 1989-06-02 1993-03-23 Abbott Laboratories Parenteral nutrition product
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
US5079016A (en) * 1990-05-16 1992-01-07 Kalamazoo Holdings, Inc. Color-stabilized carotenoid pigment compositions and foods colored therewith having increased resistance to oxidative color fading
AU660630B2 (en) * 1990-10-01 1995-07-06 Brigham And Women's Hospital Beta-carotene and vitamin E therapy for inhibition of major vascular events
DE4031094A1 (de) * 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
US5298246A (en) * 1991-01-09 1994-03-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Stable pharmaceutical composition and method for its production
CH681152A5 (de) * 1991-06-04 1993-01-29 Marigen S.A. Neue biotenside und antitumorale ester und phosphatide mit vitamin-d- und vitamin-e-verbindungen, ihre herstellung und aufarbeitung zu spontan dispergierbaren konzentraten.
EP0602137B1 (de) * 1991-09-06 2002-01-23 Cognis Australia Pty Ltd Carotinoide zusammensetzung
EP0621773B1 (de) * 1992-01-16 1998-11-25 The Board Of Regents, The University Of Texas System Formulierung und verwendung von carotenoiden in der krebsbehandlung
DE69327100T2 (de) * 1992-06-04 2000-04-13 Betatene Pty Ltd Gemisch mit hohem gehalt an cis beta-carotin

Also Published As

Publication number Publication date
EP0689426A4 (de) 1998-07-29
GR3034167T3 (en) 2000-11-30
US5897871A (en) 1999-04-27
DK0689426T3 (da) 2000-10-30
EP0689426B1 (de) 2000-05-17
PT689426E (pt) 2000-11-30
WO1994021231A1 (en) 1994-09-29
ES2149264T3 (es) 2000-11-01
DE69424537T2 (de) 2001-11-15
US5705180A (en) 1998-01-06
EP0689426A1 (de) 1996-01-03
ATE192921T1 (de) 2000-06-15
JPH08510994A (ja) 1996-11-19

Similar Documents

Publication Publication Date Title
DE69424537T2 (de) Therapeutischer wirkstoff zur behandlung von melanomen
ATE269066T1 (de) Kombinationstherapie zur prophylaxe und/oder behandlung von gutartiger prostatischer hyperplasie
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DE69400338D1 (de) Depigmentierendes Mittel zur gleichzeitigen Behandlung von Hautoberschichten und Hauttiefschichten
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
DE69909818D1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE69508192T2 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
EP0646007A1 (de) NEUE DELTA-17 UND DELTA-20 UNGESÄTIGTE UND GESATIGTE 17--g(b)-SUBSTITUIERTE-4-AZA-5-g(a)-ANDROSTAN-3-ON VERBINDUNGEN ALS INHIBITOREN VON 5-ALPHA-REDUCTASE.
DE69310528T2 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69333413D1 (de) 5-ht2-antagonisten in der behandlung venöser zustände
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
DE69526584D1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
JPS6466130A (en) High polymer carcinostatic enhancer
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ES2088681T3 (es) Mezcla esterilizante y procedimiento de esterilizacion.
UA9522A (uk) Спосіб лікування аутоімунного тиреоідиту
TR199901204T2 (xx) Kretin - ihtiva - eden alt - tabakaların muamelesi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: COGNIS AUSTRALIEN PTY.LTD., VICTORIA, AU

8339 Ceased/non-payment of the annual fee